Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. [electronic resource] by
- Comi, G
- Abramsky, O
- Arbizu, T
- Boyko, A
- Gold, R
- Havrdová, E
- Komoly, S
- Selmaj, K
- Sharrack, B
- Filippi, M
Producer: 20110215
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 16
Availability: No items available.
|
|
32.
|
|
|
33.
|
|
|
34.
|
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis. [electronic resource] by
- Radue, E-W
- Sprenger, T
- Vollmer, T
- Giovannoni, G
- Gold, R
- Havrdova, E
- Selmaj, K
- Stefoski, D
- You, X
- Elkins, J
Producer: 20160927
In:
European journal of neurology vol. 23
Availability: No items available.
|
|
35.
|
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a. [electronic resource] by
- Uher, T
- Horakova, D
- Kalincik, T
- Bergsland, N
- Tyblova, M
- Ramasamy, D P
- Seidl, Z
- Vaneckova, M
- Krasensky, J
- Havrdova, E
- Zivadinov, R
Producer: 20160129
In:
European journal of neurology vol. 22
Availability: No items available.
|
|
36.
|
|
|
37.
|
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. [electronic resource] by
- Comi, G
- Pulizzi, A
- Rovaris, M
- Abramsky, O
- Arbizu, T
- Boiko, A
- Gold, R
- Havrdova, E
- Komoly, S
- Selmaj, Kw
- Sharrack, B
- Filippi, M
Producer: 20080703
In:
Lancet (London, England) vol. 371
Availability: No items available.
|
|
38.
|
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. [electronic resource] by
- Horakova, D
- Cox, J L
- Havrdova, E
- Hussein, S
- Dolezal, O
- Cookfair, D
- Dwyer, M G
- Seidl, Z
- Bergsland, N
- Vaneckova, M
- Zivadinov, R
Producer: 20080407
In:
Journal of neurology, neurosurgery, and psychiatry vol. 79
Availability: No items available.
|
|
39.
|
Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans. [electronic resource] by
- Roth, J
- Zidovská, J
- Růzicková, S
- Havrdová, E
- Preiss, M
- Uhrová, T
- Línek, V
- Doubek, P
- Volfová, M
- Jech, R
- Bauer, J
- Růzicka, E
Producer: 20000720
In:
Sbornik lekarsky vol. 100
Availability: No items available.
|
|
40.
|
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome. [electronic resource] by
- Kalincik, T
- Guttmann, C R G
- Krasensky, J
- Vaneckova, M
- Lelkova, P
- Tyblova, M
- Seidl, Z
- De Jager, P L
- Havrdova, E
- Horakova, D
Producer: 20140102
In:
Genes and immunity vol. 14
Availability: No items available.
|